-
Mashup Score: 0
The findings validate the technique used by Medtronic and ReCor, while suggesting the U.S. companies will face competition if they target the Chinese market.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Rising Google searches for procedures suggest recovering demand at medtechs: analysts - 2 year(s) ago
Google searches for nonemergent procedures are above pre-pandemic levels, providing another data point to indicate that demand is recovering, according to a Needham report.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Companies like Stryker and Zimmer Biomet, with portfolios dominated by more “commoditized” products such as traditional hip, knee and spine devices, will find it hard to pass on rising costs to customers.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 03 key FDA topics for medtechs in 2022 - 2 year(s) ago
While the agency is looking to get back to normal operations this year, COVID-19 is poised to remain a top priority and, once again, thin resources for more traditional work, such as product reviews.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Roundup: Latest earnings show medtechs grappling with healthcare staffing shortages, supply chain - 2 year(s) ago
Medical device companies ended 2021 on an “uninspiring” note, J.P. Morgan analysts said, as they brace for a slowdown in procedures driven by a surge in COVID-19 cases due to the omicron variant.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 04 key trends for procedure-reliant medtechs in 2022 - 2 year(s) ago
Medical device companies likely will face the same challenges this year that they have been dealing with since the pandemic’s start, such as procedure volatility and hospital staffing shortages.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Healthcare staff shortages and rising COVID-19 admissions are forcing hospitals to cancel elective surgeries and postpone diagnostic and imaging procedures. BTIG sees as much as a 7% revenue hit for exposed companies.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 13 trends dragging medtechs: Supply chain constraints, inflation and hospital staffing shortages - 3 year(s) ago
J&J, ResMed and Stryker are among the companies citing one of these factors as constraining growth in the current reporting season.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Companies are spending hundreds of millions of dollars every year on direct-to-consumer advertising as the industry focuses on marketing more to patients.
Source: MedTech DiveCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The agency “will be looking for much more detailed and comprehensive” cyber threat models as part of premarket review, said Suzanne Schwartz, director of CDRH’s Office of Strategic Partnerships and Technology Innovation.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
#China #medtechs post data on #renaldenervation devices to rival Medtronic, ReCor | #medicaldevices #hypertension https://t.co/ywuTcdtHZW